Creo Medical Group PLC (AIM:CREO)
London · Delayed Price · Currency is GBP · Price in GBX 12.35
+0.23 (1.86%)
Apr 17, 2026, 8:24 AM GMT
Creo Medical Group Market Cap
Creo Medical Group has a market cap or net worth of 48.8 million as of April 16, 2026. Its market cap has decreased by -5.83% in one year.
Market Cap
48.80M
Enterprise Value
32.50M
Revenue
4.60M
Ranking
n/a
PE Ratio
54.99
Stock Price
12.35
Market Cap Chart
Since December 9, 2016, Creo Medical Group's market cap has decreased from 64.46M to 48.80M, a decrease of -24.29%. That is a compound annual growth rate of -2.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 16, 2026 | 48.80M | 22.47% |
| Dec 31, 2025 | 39.84M | -49.19% |
| Dec 31, 2024 | 78.42M | -51.05% |
| Dec 29, 2023 | 160.20M | 255.34% |
| Dec 30, 2022 | 45.08M | -83.01% |
| Dec 31, 2021 | 265.37M | -13.37% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 9, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 231.38B |
| GSK plc | 87.49B |
| Haleon | 31.84B |
| Smith & Nephew | 10.79B |
| Ondine Biomedical | 58.45M |
| Hemogenyx Pharmaceuticals | 55.58M |
| Faron Pharmaceuticals Oy | 51.41M |
| Kooth | 49.51M |